Ascelia Pharma Receives FDA Complete Response Letter For Orviglance NDA

Ascelia Pharma AB OMXSTO:ACE:

• RECEIVES FDA COMPLETE RESPONSE LETTER FOR ORVIGLANCE NDA

• FDA REQUESTS ADDITIONAL CLINICAL DATA AND DOCUMENTATION FOR ORVIGLANCE NDA